Device / Technology News

RSS

fMRI scans can identify biological signs of autism in toddlers

The biological causes of autism are still not understood. A diagnosis of autism is only possible after ages three or four and the tests are subjective, based on behavioral symptoms. Now, in research that appeared in Neuron, scientists at the Weizmann Institute of Science, Carnegie Mellon University, and the University of California, San Diego have found, for the first time, a method that can accurately identify a biological sign of autism in very young toddlers.

26 Jul 2011

CHroniCles site aims to document important stories of health centers

The RCHN Community Health Foundation and the Geiger Gibson Program in Community Health Policy at the George Washington University School of Public Health and Health Services today announced the launch of CHroniCles, a dynamic, multi-media website dedicated to the living history of the community health center movement.

26 Jul 2011

Resolute drug-eluting stent superior to Taxus DES for coronary artery disease

The Resolute drug-eluting stent (DES) from Medtronic, Inc., showed superiority to Boston Scientific Corp.'s Taxus DES on the primary endpoint of the RESOLUTE Japan clinical study: in-stent late lumen loss at eight months.

26 Jul 2011

New highly sensitive method can assess the extent of titanium leaks from implants

A new strategy to quantify the levels of titanium in the blood of patients fitted with titanium orthopaedic implants is presented in Analytical and Bioanalytical Chemistry, a Springer journal.

26 Jul 2011

Phadia demonstrates ImmunoCAP Molecular Allergy testing at AACC 2011

Today, at the 2011 American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, Phadia, the global leader in allergy and autoimmune disease-related diagnostics, demonstrates how ImmunoCAP Molecular Allergy can help improve the diagnosis and management of food allergy.

26 Jul 2011

Healthcare IT Technician certificate now available from CompTIA

A new professional credential aimed at information technology (IT) professionals who install, manage and troubleshoot electronic health records systems for the nation's healthcare providers is now available from CompTIA, the non-profit trade association for the IT industry.

26 Jul 2011

GE Healthcare introduces Veo CT image reconstruction technology in Canada

GE Healthcare announced the introduction of a breakthrough Computed Tomography (CT) image reconstruction technology, called Veo, in Canada. The industry's first Model-based Iterative Reconstruction (MBIR) technique, Veo is designed to help physicians deliver accurate diagnoses by enabling high CT image quality at significantly lower dose.

25 Jul 2011

Media outlets examine mobile phones' effect on health, development in Africa

PBS NewsHour examines how the Canadian organization MEDA is using text messages to track malaria supplies in local clinics and retailers in Tanzania. The piece includes a related video featuring a MEDA employee giving a tour of the program (Cheers, 7/22).

25 Jul 2011

Enrollment commences in Lutonix LEVANT 2 drug-coated balloon IDE trial for PAD

Lutonix today announced the first patient enrolled in the LEVANT 2 clinical trial, a global, multicenter, randomized trial evaluating the safety and efficacy of the Moxy™ Drug Coated Balloon compared to a standard angioplasty balloon for the treatment of peripheral arterial disease (PAD). The first case was performed at St. John's Hospital in Springfield, IL by Dr. Jeff Goldstein.

25 Jul 2011

Advanced Instruments launches Advanced Automated Osmometer

Advanced Instruments, Inc., today introduced the A2O Advanced Automated Osmometer, a multi-sample instrument that sets new benchmarks for analytical performance, ease of use, and true walk away operation capabilities in osmolality testing.

25 Jul 2011

Illinois Bone and Joint Institute upgrades to High Field Open MRI System

Illinois Bone and Joint Institute, MRI Services, is proud to announce the installation of the first High Field Open MRI serving patients of Chicago and Northeastern Illinois.

25 Jul 2011

Accelr8 and Novartis extend collaboration for BACcel system development

Accelr8 Technology Corporation announced that Accelr8 and Novartis have extended their program agreement through September 30, 2011. Having reviewed new data, Novartis will now install a system in their own facility to expand development capacity.

25 Jul 2011

Waters receives CE mark for MassTrak Immunosuppressants XE Kit

Waters Corporation (NYSE: WAT) today announced that its MassTrak™ Immunosuppressants XE Kit is now CE-marked in accordance with the IVD Directive 98/79/EC, for the quantitative measurement of the immunosuppressive drugs tacrolimus in liver and kidney transplant patients and everolimus in adult kidney and cardiac transplant patients from human whole blood samples as an aid in the management of immunosuppressant drug therapy.

25 Jul 2011

Australian TGA approves GI Dynamics EndoBarrier Gastrointestinal Liner for type 2 diabetes and obesity

GI Dynamics, Inc., a company focused on the development and commercialization of effective, non-surgical approaches for the treatment of type 2 diabetes and obesity, today announced that the Australian Therapeutic Goods Administration (TGA) has approved the EndoBarrier® Gastrointestinal Liner for inclusion on the Australian Register of Therapeutic Goods (ARTG).

25 Jul 2011

Valeritas' V-Go Disposable Insulin Delivery Device receives CE Mark approval

Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification.

25 Jul 2011

Better targeting of pharmaceuticals to patient's genetic profile could save around $110B annually

Genetic testing made possible by the mapping of the human genome can help the US cut costs and create jobs while at the same time improving survival rates for such diseases as cancer, HIV, and heart disease.

25 Jul 2011

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.

25 Jul 2011